BamSEC and AlphaSense Join Forces
Learn More

Atea Pharmaceuticals Inc.

NASDAQ: AVIR    
Share price (1/9/26): $3.45    
Market cap (1/9/26): $270 million
Search in Documents
Key Exhibits
External Links

Transcripts

CY 2025
Other Revised 11/13/25 Atea Pharmaceuticals, Inc. - Special Call 11/13/25 Earnings Revised 11/12/25 Atea Pharmaceuticals, Inc., Q3 2025 Earnings Call, Nov 12, 2025 11/12/25 Other Revised 09/09/25 Atea Pharmaceuticals, Inc. Presents at Morgan Stanley 23rd Annual Global Healthcare Conference, Sep-09-2025 01:05 PM 09/09/25 Earnings Revised 10/03/25 Atea Pharmaceuticals, Inc., Q2 2025 Earnings Call, Aug 07, 2025 08/07/25 Other Revised 05/14/25 Atea Pharmaceuticals, Inc. - Special Call 05/14/25 Earnings Revised 03/06/25 Atea Pharmaceuticals, Inc., Q4 2024 Earnings Call, Mar 06, 2025 03/06/25 Other Revised 01/16/25 Atea Pharmaceuticals, Inc. Presents at 43rd Annual J.P. Morgan Healthcare Conference 2025, Jan-15-2025 05:15 PM 01/15/25
CY 2024
Earnings Revised 11/07/24 Atea Pharmaceuticals, Inc., Q3 2024 Earnings Call, Nov 07, 2024 11/07/24 Earnings Revised 08/09/24 Atea Pharmaceuticals, Inc., Q2 2024 Earnings Call, Aug 07, 2024 08/07/24 Earnings Revised 05/14/24 Atea Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 14, 2024 05/14/24 Earnings Revised 02/28/24 Atea Pharmaceuticals, Inc., Q4 2023 Earnings Call, Feb 28, 2024 02/28/24 Other Revised 01/10/24 Atea Pharmaceuticals, Inc. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-10-2024 10:30 AM 01/10/24
CY 2023
Earnings Revised 11/08/23 Atea Pharmaceuticals, Inc., Q3 2023 Earnings Call, Nov 08, 2023 11/08/23 Other Revised 01/05/24 Atea Pharmaceuticals, Inc. Presents at Morgan Stanley 21st Annual Global Healthcare Conference 2023, Sep-13-2023 10:10 AM 09/13/23 Earnings Revised 04/18/24 Atea Pharmaceuticals, Inc., Q2 2023 Earnings Call, Aug 08, 2023 08/08/23 Earnings Revised 06/04/23 Atea Pharmaceuticals, Inc., Q1 2023 Earnings Call, May 08, 2023 05/08/23 Earnings Revised 02/28/23 Atea Pharmaceuticals, Inc., Q4 2022 Earnings Call, Feb 28, 2023 02/28/23 Other Revised 01/11/23 Atea Pharmaceuticals, Inc. Presents at 41st Annual J.P. Morgan Healthcare Conference, Jan-11-2023 03:00 PM 01/11/23
CY 2022
Earnings Revised 11/07/22 Atea Pharmaceuticals, Inc., Q3 2022 Earnings Call, Nov 07, 2022 11/07/22 Other Revised 09/13/22 Atea Pharmaceuticals, Inc. Presents at Morgan Stanley 20th Annual Global Healthcare Conference, Sep-13-2022 12:55 PM 09/13/22 Other Revised 09/13/22 Atea Pharmaceuticals, Inc. - Special Call 09/13/22 Earnings Revised 04/01/24 Atea Pharmaceuticals, Inc., Q2 2022 Earnings Call, Aug 08, 2022 08/08/22 Earnings Revised 05/10/22 Atea Pharmaceuticals, Inc., Q1 2022 Earnings Call, May 10, 2022 05/10/22 Earnings Revised 02/28/22 Atea Pharmaceuticals, Inc., Q4 2021 Earnings Call, Feb 28, 2022 02/28/22 Other Revised 01/10/22 Atea Pharmaceuticals, Inc. Presents at JPMorgan 40th Annual Healthcare Conference, Jan-10-2022 08:15 AM 01/10/22
CY 2021
Earnings Revised 11/11/21 Atea Pharmaceuticals, Inc., Q3 2021 Earnings Call, Nov 11, 2021 11/11/21 Other Revised 10/19/21 Atea Pharmaceuticals, Inc. - Special Call 10/19/21 Other Revised 09/14/21 Atea Pharmaceuticals, Inc. Presents at Morgan Stanley 19th Annual Global Healthcare Conference, Sep-14-2021 02:00 PM 09/14/21 Earnings Revised 08/12/21 Atea Pharmaceuticals, Inc., Q2 2021 Earnings Call, Aug 12, 2021 08/12/21 Earnings Revised 05/13/21 Atea Pharmaceuticals, Inc., Q1 2021 Earnings Call, May 13, 2021 05/13/21 Earnings Revised 03/30/21 Atea Pharmaceuticals, Inc., Q4 2020 Earnings Call, Mar 30, 2021 03/30/21
CY 2017
Other Revised 06/08/23 Aviragen Therapeutics, Inc., Vaxart, Inc. - M&A Call 10/30/17 Other Revised 06/08/23 Aviragen Therapeutics, Inc., Q2 2017 Earnings Call, Feb 02, 2017 02/02/17
CY 2016
Other Revised 06/08/23 Aviragen Therapeutics, Inc., Q1 2017 Earnings Call, Nov 03, 2016 11/03/16 Other Revised 06/08/23 Aviragen Therapeutics, Inc., Q4 2016 Earnings Call, Sep 14, 2016 09/14/16 Other Revised 06/08/23 Aviragen Therapeutics, Inc., Q3 2016 Earnings Call, May 05, 2016 05/05/16
CY 2012
Other Revised 06/08/23 Biota Holdings Ltd., Nabi Biopharmaceuticals - M&A Call 04/23/12